Cooley advised Personalis on its $154.9 million initial public offering of 9,109,725 shares of common stock, including full exercise of the underwriters’ option to purchase additional shares. Personalis, whose securities now trade on the Nasdaq Global Market under the symbol “PSNL,” is a growing cancer genomics company. Partners James Kitch and Michael Tenta led the Cooley team.
